1. World Health Organization. Declaration of alma-ata. Regional Office for Europe: Denmark, Copenhagen; 1978. p. 4.
2. Mosadeghrad A, Aarabi M, Abbasi M. Family practice: A conceptual review. Hakim. 2021;24(2):172-91. [In Persian]
3. Mobasheri F, Jafarzadeh S, Bahramali E. The level of satisfaction of family physician program in urban population of Fasa from 2014 to 2015. J Fasa Univ Med Sci. 2017;7(2):190-8. [In Persian]
4. Kabir MJ, Ashrafian Amiri H, Rabiee M, Keshavarzi A, Hoseini S, Nasrollahpour Shirvani D. Health care providers, satisfaction in the urban family physician program of Iran. Nursing And Midwifery Journal. 2018;16(2):92-100. [in Persian]
5. Damari B, Vosough Moghaddam A, Rostami Gooran N, Kabir MJ. Evaluation of the urban family physician and referral system program in Fars and Mazandran provinces: History, achievements, challenges and solutions. J Sch Publ Health Inst Publ Health Res. 2016;14(2):17-38. [In Persian]
6. Behzadifar M, Behzadifar M, Heidarvand S, Gorji HA, Aryankhesal A, Taheri Moghadam Sh, et al. The challenges of the family physician policy in Iran: A systematic review and meta-synthesis of qualitative researches. Fam Pract. 2018 ;35(6): 652-60. [
DOI:10.1093/fampra/cmy035]
7. Fardid M, Jafari M, Vosoogh Moghaddam A, Ravaghi H. Challenges and strengths of implementing urban family physician program in Fars province. J Educ Health Promot. 2019;8:1-8.
8. Mosadeghrad AM. Managing conflict of interest in health sector: A letter to the editor. Tehran University Medical Journal. 2022;80(10):847-8. [In Persian]
9. Field MJ, Lo B, editors. Conflict of interest in medical research, education and practice. Washington, DC: The National Academies Press; 2009.
10. Mosadeghrad AM, Ferlie E. Total quality management in healthcare. In: Ortenblad A, Abrahamson Lofstrom C, Sheaff R, editors. Management innovations for healthcare organizations: adopt, abandon or adapt? New York: Routledge; 2016. p. 378-96.
11. Mosadeghrad AM. Comments on Iran hospital accreditation system. Iran J Public Health. 2016; 45(6):837-9.
12. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356(17):1742-50. [
DOI:10.1056/NEJMsa064508]
13. Kaiser Family Foundation. National survey of physicians part II: Doctors and prescription drugs. Menlo Park, CA: KFF; 2002. 9 p.
14. Morgan MA, Dana J, Loewenstein G, Zinberg S, Schulkin J. Interactions of doctors with the pharmaceutical industry. J Med Ethics. 2006;32(10):559-63. [
DOI:10.1136/jme.2005.014480]
15. Neyazi N, Mosadeghrad AM, Afshari M, Isfahani P, Safi N. Strategies to tackle non-communicable diseases in Afghanistan: A scoping review. Front Public Health. 2023;11:1-15. [
DOI:10.3389/fpubh.2023.982416]
16. Arksey H, O'Malley L. Scoping studies: Towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19-32. [
DOI:10.1080/1364557032000119616]
17. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess B, editors. Analyzing qualitative data. London: Routledge; 1994. p. 187-208.
18. Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, et al. The vexing problem of guidelines and conflict of interest: A potential solution. Ann Intern Med. 2010;152(11):738-41. [
DOI:10.7326/0003-4819-152-11-201006010-00254]
19. Hensley S, Martinez B. To sell their drugs, companies increasingly rely on doctors. Wall St J (East Ed). 2005.
20. Rosenthal E. Drug makers' push leads to vaccines' fast rise. New York Times. 2008:A1.
21. Wazana A. Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA. 2000;283(3):373-80. [
DOI:10.1001/jama.283.3.373]
22. Sandberg WS, Carlos R, Sandberg EH, Roizen MF. The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products. Acad Med. 1997;72(10):916-8. [
DOI:10.1097/00001888-199710000-00024]
23. Alper PR. Primary care in transition. JAMA. 1994;272(19):1523-7. [
DOI:10.1001/jama.1994.03520190069037]
24. Ghiasipour M, Mosadeghrad AM, Arab M, Jaafaripooyan E. Leadership challenges in health care organizations: The case of Iranian hospitals. Med J Islam Repub Iran. 2017;31:1-8. [
DOI:10.14196/mjiri.31.96]
25. Esfahani P, Mosadeghrad AM, Akbarisari A. The success of strategic planning in health care organizations of Iran. Int J Health Care Qual Assur. 2018;31(6):563-74. [
DOI:10.1108/IJHCQA-08-2017-0145]
26. Chimonas S, Rothman DJ. New federal guidelines for physician-pharmaceutical industry relations: The politics of policy formation. Health Aff (Millwood). 2005;24(4):949-60. [
DOI:10.1377/hlthaff.24.4.949]
27. Bodenheimer T, Berenson RA, Rudolf P. The primary care-specialty income gap: Why it matters. Ann Intern Med. 2007;146(4):301-6. [
DOI:10.7326/0003-4819-146-4-200702200-00011]
28. Mosadeghrad AM, Isfahani P. Strategies for reducing induced demand in the health system: A scoping review. Journal of Health Administration. 2023;25(4):45-68.
29. National Health Service England. Managing conflicts of interest in the NHS. 2017. [
DOI:10.1136/bmj.j1590]
30. Fischer MA, Keough ME, Baril JL, Saccoccio L, Mazor KM, Ladd E, et al. Prescribers and pharmaceutical representatives: Why are we still meeting? J Gen Intern Med. 2009;24(7):795-801. [
DOI:10.1007/s11606-009-0989-6]